Holen Sie sich die Stockscreener-App
94.09
2.79%
2.55
Schlusskurs vom Vortag:
$91.54
Offen:
$90.85
24-Stunden-Volumen:
232.88K
Relative Volume:
1.27
Marktkapitalisierung:
$1.11B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+12.39%
1M Leistung:
+24.37%
6M Leistung:
+309.09%
1J Leistung:
+0.00%
1-Tages-Spanne:
$90.00
$95.43
1-Wochen-Bereich:
$80.64
$101.94
52-Wochen-Spanne:
$11.17
$101.94
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Firmenname
Palvella Therapeutics Inc
Sektor
Branche
Telefon
(484) 253-1461
Adresse
353 W. LANCASTER AVENUE, WAYNE
Vergleichen Sie PVLA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
94.09 | 1.08B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-09-09 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-06 | Eingeleitet | Raymond James | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-04-09 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-26 | Eingeleitet | Stifel | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-02-05 | Eingeleitet | TD Cowen | Buy |
| 2024-12-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-03-19 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Eingeleitet | Jefferies | Buy |
| 2018-01-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-30 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-08-05 | Fortgesetzt | ROTH Capital | Buy |
| 2015-08-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Palvella Therapeutics Inc Aktie (PVLA) Neueste Nachrichten
Is Frog Cellsat Limited Positioned to Benefit From Secular ShiftsCandlestick Trading Patterns & Discover Your Financial Freedom Formula - earlytimes.in
Palvella Therapeutics stock hits 52-week high at $98.60 By Investing.com - Investing.com Canada
Will Palvella Therapeutics Inc. (PI6) stock rise with strong economyQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up Following Analyst Upgrade - Defense World
Palvella Therapeutics (NASDAQ:PVLA) Stock Rating Upgraded by Raymond James Financial - Defense World
Palvella Therapeutics Inc (PVLA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Why Palvella Therapeutics Inc. stock remains a top recommendationRecession Risk & Low Drawdown Investment Ideas - newser.com
Will Palvella Therapeutics Inc. stock continue dividend increasesWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
Can Palvella Therapeutics Inc. stock beat analyst upgradesJuly 2025 Volume & AI Driven Stock Reports - newser.com
Raymond James Upgrades Palvella Therapeutics (PVLA) - Nasdaq
Can momentum traders help lift Palvella Therapeutics Inc.2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Raymond James upgrades Palvella Therapeutics stock rating to Strong Buy By Investing.com - Investing.com Canada
Why global investors buy Palvella Therapeutics Inc. (PI6) stockIndex Update & Technical Pattern Based Buy Signals - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectory2025 Risk Factors & Expert Approved Trade Ideas - newser.com
Raymond James upgrades Palvella Therapeutics stock rating to Strong Buy - Investing.com India
Can Palvella Therapeutics Inc. stock sustain market leadership2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.Portfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
How geopolitical risks impact Palvella Therapeutics Inc. (PI6) stock2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdownJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly - MyChesCo
Cantor Fitzgerald Issues Negative Estimate for PVLA Earnings - Defense World
Palvella Therapeutics (PVLA) Gets a Buy from LifeSci Capital - The Globe and Mail
Can Palvella Therapeutics Inc. stock deliver consistent earnings growthJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge fundsInflation Watch & Fast Entry Momentum Alerts - newser.com
Lifesci Capital Has Negative Outlook of PVLA FY2025 Earnings - Defense World
HC Wainwright Issues Pessimistic Forecast for PVLA Earnings - Defense World
Why Palvella Therapeutics Inc. (PI6) stock is upgraded to buyPortfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Canaccord Genuity Maintains Palvella Therapeutics (PVLA) Buy Recommendation - Nasdaq
Finanzdaten der Palvella Therapeutics Inc-Aktie (PVLA)
Es liegen keine Finanzdaten für Palvella Therapeutics Inc (PVLA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):